2022 - Research.com Best Female Scientist Award
2019 - Member of the National Academy of Sciences
2011 - Fellow of the American Academy of Arts and Sciences
Martine F. Roussel integrates Molecular biology and Transfection in her research. As part of her studies on Transfection, she often connects relevant subjects like 3T3 cells. In her articles, Martine F. Roussel combines various disciplines, including 3T3 cells and Cell culture. By researching both Cell culture and Molecular biology, Martine F. Roussel produces research that crosses academic boundaries. Her research on Cell biology often connects related areas such as Phosphorylation. Phosphorylation and Protein kinase C are two areas of study in which she engages in interdisciplinary work. Her research on Protein kinase C frequently links to adjacent areas such as Cell biology. Her research ties Cyclin E and Biochemistry together. In her research, she undertakes multidisciplinary study on Cyclin E and Kinase.
Martine F. Roussel usually deals with Flow cytometry and limits it to topics linked to Molecular biology and Glycoprotein. In her study, Martine F. Roussel carries out multidisciplinary Glycoprotein and Gene research. In her research, Martine F. Roussel undertakes multidisciplinary study on Gene and Complementary DNA. Her research brings together the fields of Phosphorylation and Cell biology. As part of her studies on Phosphorylation, Martine F. Roussel frequently links adjacent subjects like Cell biology. Martine F. Roussel merges many fields, such as Biochemistry and Immunology, in her writings. Martine F. Roussel performs integrative study on Immunology and Biochemistry in her works. She combines Genetics and Cancer research in her research. By researching both Cancer research and Genetics, she produces research that crosses academic boundaries.
Martine F. Roussel brings together Cancer research and Cancer to produce work in her papers. With her scientific publications, her incorporates both Cancer and Transgene. Martine F. Roussel applies her multidisciplinary studies on Transgene and Genetically modified mouse in her research. In her research, she undertakes multidisciplinary study on Genetically modified mouse and Genetics. Her Genetics study frequently links to related topics such as Medulloblastoma. Her Medulloblastoma study frequently draws connections between related disciplines such as Cancer research. Her study brings together the fields of Suppressor and Gene. Her Gene research extends to the thematically linked field of Suppressor. She merges many fields, such as Embryonic stem cell and Stem cell, in her writings.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
J. Alan Diehl;Mangeng Cheng;Martine F. Roussel;Charles J. Sherr.
Genes & Development (1998)
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF
Takehiko Kamijo;Frederique Zindy;Martine F. Roussel;Dawn E. Quelle.
The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1
Charles J. Sherr;Carl W. Rettenmier;Rosalba Sacca;Martine F Roussel.
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Hitoshl Matsushime;Martine F. Roussel;Martine F. Roussel;Richard A. Ashmun;Charles J. Sherr;Charles J. Sherr.
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Frederique Zindy;Christine M. Eischen;David H. Randle;Takehiko Kamijo.
Genes & Development (1998)
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
Mangeng Cheng;Paul Olivier;Paul Olivier;J.Alan Diehl;J.Alan Diehl;Matthew Fero;Matthew Fero.
The EMBO Journal (1999)
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
D. E. Quelle;R. A. Ashmun;S. A. Shurtleff;Jun-Ya Kato.
Genes & Development (1993)
Nucleolar Arf sequesters Mdm2 and activates p53.
Jason D. Weber;Jason D. Weber;Laura J. Taylor;Martine F. Roussel;Charles J. Sherr.
Nature Cell Biology (1999)
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
Hitoshi Matsushime;Mark E. Ewen;David K. Strom;Jun-Ya Kato.
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Takehiko Kamijo;Jason D. Weber;Gerard Zambetti;Frederique Zindy.
Proceedings of the National Academy of Sciences of the United States of America (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: